NRSNW NeuroSense Therapeutics Ltd.: institutional ownership and insider trading
4 funds reported holding $50.8K of NeuroSense Therapeutics Ltd. in their latest 13F filings; in Q2 2026 funds net sold $18, with 0 new positions and 0 funds selling out; over the last 12 months insiders bought $400K and sold $0 on the open market.
Largest institutional holders of NRSNW
- CLEAR STREET LLC — $40.4K
- Empery Asset Management, LP — $6.33K
- Clear Street Group Inc. — $3.97K
- UBS Group AG (UBS) — $73
Recent NRSNW insider trades
- Jun 16, 2026: Ben-Noon Alon bought 250,000 shares ($200K)
- Jun 16, 2026: Eisenberg Or bought 250,000 shares ($200K)